GT Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,597,000 over the previous period. Total operating expenses were $13,576,000.
Profit Margin
| 2014 | 61K | -23.48M | -38506.56% |
|---|---|---|---|
| 2015 | 27K | -32.72M | -121207.41% |
| 2016 | 0 | 21.03M | |
| 2017 | 0 | -143.24M | |
| 2018 | 0 | -259.18M | |
| 2019 | 0 | -40.77M | |
| 2020 | 0 | -31.61M | |
| 2021 | 0 | -58.69M | |
| 2022 | 0 | -20.50M | |
| 2023 | 0 | -7.59M |
GTBP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27K | 61K |
Cost of revenue | 0 | 0 | 0 | 0 | 4K | 7K | 2K | 1K | 2K | 57K |
Gross profit | 0 | 0 | 0 | 0 | -4K | -7K | -2K | -1K | 25K | 4K |
Operating exp. | ||||||||||
Research and development | 6.46M | 8.81M | 9.59M | 485K | 1.66M | 9.06M | 1.06M | 975K | 1M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 13.57M | 21.25M | 57.51M | 6.76M | 11.45M | 21.55M | 135.57M | 9.37M | 8.95M | 2.4M |
Operating income | -13.57M | -21.25M | -57.51M | -6.76M | -16.05M | -250.06M | -135.57M | -9.37M | -8.92M | -2.39M |
Other income (expenses), net | 5.97M | 373K | -498K | -21.53M | -22.59M | -228.51M | -7.67M | 36.96M | -12.53M | -21.10M |
Income before tax | -7.59M | -20.88M | -58.01M | -28.29M | -38.64M | -259.18M | -143.24M | 21.03M | -32.72M | -23.48M |
Income tax expense | 0 | -381K | 680K | 3.32M | 2.12M | -228.51M | 7.67M | -30.40M | 17.03M | 5.14M |
Net income | -7.59M | -20.50M | -58.69M | -31.61M | -40.77M | -259.18M | -143.24M | 21.03M | -32.72M | -23.48M |
Earnings per share | ||||||||||
Basic EPS | -5.64 | -19.3 | -62.54 | -216.29 | -361.49 | -87.7 | -145.22 | 4.39K | -69.62K | -50.62K |
Diluted EPS | -5.64 | -19.3 | -62.54 | -216.29 | -361.49 | -87.7 | -145.22 | 4.39K | -69.62K | -50.62K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |